Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 9:34 PM
Ignite Modification Date:
2025-12-24 @ 9:34 PM
NCT ID:
NCT00518232
Eligibility Criteria:
Inclusion Criteria:
* Patients who used to be treated their Attention-deficit hyperactivity disorder with IR-MPH less than 70 mg/day (inclusive) for at least one month without severe adverse events or possible contraindications with MPH
* Patients must be living with the parent/caregiver who can complete the questionnaires during the study
* Patients or parent/caregiver without any psychotic disease or any mental situation which may cause the concern to properly complete the questionnaires
Exclusion Criteria:
* Known to be non-responders to methylphenidate
* Marked anxiety, tension, aggression/agitation
* Known or suspected mental retardation or significant learning disorder
* Glaucoma, ongoing seizure disorder, psychotic disorder, diagnosis or family history of Tourette's disorder, bipolar disorder, eating disorder
* Subject who require drug therapy or hospitalization for treatment of a mood or anxiety disorder
* other psychotropic medication subject is taking at study entry could be continued during study period they were maintained at a stable dose for a minimum of 4 weeks pre-study entry
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
6 Years
Maximum Age:
19 Years
Study:
NCT00518232
Study Brief:
Protocol Section:
NCT00518232